Differentiation of classical and novel antipsychotics using animal models

International Clinical Psychopharmacology

Volumn 12, Issue SUPPL. 1, 1997, Pages

  Arnt, Jørn ^a   Skarsfeldt, Torben ^a   Hyttel, John ^a  

^a H LUNDBECK A S   (Denmark)

Author keywords

Atypical antipsychotic drugs; Behavioral pharmacology; Extrapyramidal syndromes; Limbic; Morris water maze; Nigrostriatal; Primates; Rats

Indexed keywords

CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE; SERTINDOLE;

ANIMAL; ANIMAL MODEL; BEHAVIOR; COGNITION; CONFERENCE PAPER; DRUG DISCRIMINATION; DRUG DOSE; EXTRAPYRAMIDAL SYNDROME; LIMBIC SYSTEM; MODEL; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0030896959     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-199702001-00003     Document Type: Conference Paper

References (67)

1. Amt J (1995) Differential effects of classical and newer antipsychotics on the hypermotility induced by two dose levels of d-amphetamine. Eur J Pharmacol 283:55-62.
2. Beasley CM, Tollefson G, Tran P, et al. (1996) Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial. Neuropsychopharmacology 14:111-123.
3. Beatty WW, Rush JR (1983) Spatial working memory in rats: effects of monoaminergic antagonists. Pharmacol Biochem Behav 18:7-12.
4. Beninger RJ (1983) The role of dopamine in locomotor activity and learning. Brain Res Rev 6:173-196.
5. Bowers MB Jr (1980) Biochemical processes in schizophrenia: an update. Schizophr Bull 6:393-403.
6. Bunney BS (1992) Clozapine: a hypothesised mechanism for its unique clinical profile. Br J Psychiatry 17 (suppl):17-21.
7. Bunney BS and Grace AA (1978) Acute and chronic haloperidol treatment: comparison of effects on nigral dopaminergic cell activity. Life Sci 23:1715-1728.
8. Bunney BS, Walters JR, Roth RH, et al. (1973) Dopaminergic neurons: effects of antipsychotic drugs and amphetamine on single cell activity. J Pharmacol Exp Ther 185:560-571.
9. Bymaster FP, Calligaro DO, Falcone JF, et al. (1996) Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology 14:87-96.
10. Carlsson A (1978) Antipsychotic drugs, neurotransmitters, and schizophrenia. Am J Psychiatry 135:164-173.
11. Casey DE (1987) Tardive dyskinesia. In: Psychopharmacology. The Third Generation of Progress. Edited by Meltzer HY. NewYork: Raven Press; pp 1411-1419.
12. Casey DE (1996) Behavioral effects of sertindole, risperidone, clozapine and haloperidol in Cebus monkeys. Psychopharmacology 124:134-140.
13. Chiodo LA, Bunney BS (1983) Typical and atypical neuroleptics: different effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons. J Neurosci 3:1607-1619.
14. Chiodo LA, Bunney BS (1985) Possible mechanisms by which repeated clozapine administration differentially affects the activity of two subpopulations of midbrain dopamine neurons. J Neurosci 5:2539-2544.
15. Costall B, Naylor RJ (1976a) A comparison of the abilities of typical neuroleptic agents and of thioridazine, clozapine, sulpiride and metoclopramide to antagonise the hyperactivity induced by dopamine applied intracerebrally to areas of the extrapyramidal and mesolimbic systems. Eur J Pharmacol 40:9-19.
16. Costall B, Naylor RJ (1976b) Antagonism of the hyperactivity induced by dopamine applied intracerebrally to the nucleus accumbens septi by typical neuroleptics and by clozapine, sulpiride and thioridazide. Eur J Pharmacol 35:161-168.
17. Deutch AY, Bourdelais AJ, Zahm DS (1993)The nucleus accumbens core and shell: accumbal compartments and their functional attributes. In: Limbic Circuits and Neuropsychiatry. Edited by Kalivas PW, Barnes CD. Boca Raton, Florida: CRC Press; pp 45-88.
18. Farde L, Nordström AL (1992) PET analysis indicates atypical central dopamine receptor occupancy in clozapine-treated patients. Br J Psychiatry 60:30-33.
19. 2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs. Arch Gen Psychiatry 45:71-76.
20. 2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics. Psychopharmacology 99:S28-S31.
21. Fink-Jensen A and Kristensen P (1994) Effects of typical and atypical neuroleptics on Fos protein expression in the rat forebrain. Neurosci Lett 182:115-118.
22. Fink-Jensen A, Hansen L, Hansen JB, et al. (1996) Regional differences in the effect of haloperidol and atypical neuroleptics on interstitial levels of DOPAC in the rat forebrain. An in vivo microdialysis study. J Psychopharmacol 10:119-125.
23. Frith CD (1984) Schizophrenia, memory and anticholinergic drugs. J Abnorm Psychol 93:339-341.
24. Glenthøj B, Mogensen J, Laursen H, et al. (1993) Electrical sensitization of the meso-limbic dopaminergic system in rats: a pathogenetic model for schizophrenia. Brain Res 619:39-54.
25. Goldstein JM (1995) Pre-clinical pharmacology of new atypical antipsychotics in late stage development. Expert Opin Invest Drugs 4:291-298.
26. Goldstein JM, Litwin LC, Sutton EB, et al. (1993) Seroquel, electrophysiological profile of a potential atypical antipsychotic. Psychopharmacology 112:293-298.
27. Grace AA (1991) Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience 41:1-24.
28. Grace AA (1992) The depolarization block hypothesis of neuroleptic action: implications for the etiology and treatment of schizophrenia. J Neural Transm Suppl 36:91-131.
29. Grenhoff J, Svensson TH (1989) Clonidine modulates dopamine cell firing in rat ventral tegmental area. Eur J Pharmacol 165:11-18.
30. Grenhoff J, Tung C-S, Ugedo L, et al. (1990) Effects of amperozide, a putative antipsychotic drug, on rat midbrain dopamine neurons recorded in vivo. Pharmacol Toxicol 66 (suppl 1):29-33.
31. Hirsch SR, Link CGG, Goldstein JM, et al. (1996) A new atypical antipsychotic drug. Br J Psychiatry 166 (suppl 28):45-56.
32. Hornykiewicz O (1978) Psychopharmacological implications of dopamine and dopamine antagonists: a critical evaluation of current evidence. Neuroscience 3:773-783.
33. Kalivas PW, Duffy P (1989) Similar effects of daily cocaine and stress on mesocorticolimbic dopamine neurotransmission in the rat. Biol Psychiatry 25:913-928.
34. van Kammen DP, McEvoy JP, Targum SD, et al. (1996) A randomized, controlled, dose-ranging trial of sertindole in patients with schizophrenia. Psychopharmacology 124:168-175.
35. Kerwin R, Taylor D (1996) New antipsychotics: a review of their current status and clinical potential. CNS Drugs 6:72-82.
36. Levin ED (1988) Psychopharmacological effects in the radial-arm maze. Neurosci Biobehav Rev 12:169-175.
37. Lieberman JA, Kinon BJ, Loebel AD (1990) Dopaminergic mechanisms in idiopathic and drug-induced psychosis. Schizophr Bull 16:97-110.
38. Lydon RG, Nakajima S (1992) Differential effects of scopolamine on working and reference memory depend upon level of training. Pharmacol Biochem Behav 43:645-650.
39. Marder SR, Meibach RC (1994) Risperidone in the treatment of schizophrenia. Am J Psychiatry 151:825-835.
40. McEntee WJ, Crook TH (1991) Serotonin, memory and the aging brain. Psychopharmacology 103:143-149.
41. McNamara RK, Skelton RW (1992) Assessment of a cholinergic contribution to chlordiazepoxide-induced deficits of place learning in the Morris water maze. Pharmacol Biochem Behav 41:529-538.
42. Moore NA, Calligaro DO, Wong DT, et al. (1993) The pharmacology of olanzapine and other new antipsychotic agents. Curr Opin Invest Drugs 2:281-293.
43. Morris RGM (1984) Development of a water maze procedure for studying spatial learning in the rat. J Neurosci Methods 11:47-60.
44. Ogren SO, Hall H, Kohler C, et al. (1984) Remoxipride, a new potential antipsychotic compound with selective antidopaminergic action in the rat brain. Eur J Pharmacol 102:459-474.
45. Peuskens J (1995) Risperidone in the treatment of patients with chronic schizophrenia: a multi-national, multi-centre, double-blind, parallel-group study versus haloperidol. Br J Psychiatry 166:712-726.
46. 2 dopamine receptor blockade hypothesis of schizophrenia. Lancet 340:199-202.
47. Rasmussen K, Stockton ME (1993) Olanzapine, a novel atypical antipsychotic, has electrophysiological effects on A9 and A10 dopamine neurons similar to clozapine [abstract]. Meeting of the American College of Neuropsychopharmacology, December 1993. Nashville, Tennessee: American College of Neuropsychopharmacology.
48. Robertson GS, Fibiger HC (1992) Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine. Neuroscience 46:315-328.
49. Robertson GS, Fibiger HC (1996) Effects of olanzapine on regional c-fos expression in rat forebrain. Neuropsychopharmacology 14:105-110.
50. Saltz BL, Woerner M, Kane JM, et al. (1991) Prospective study of tardive dyskinesia incidence in the elderly. JAMA 266:2402-2406.
51. Sánchez C, Arnt J, Dragsted N, et al. (1991) Neurochemical and in vivo pharmacological profile of sertindole, a limbic-selective neuroleptic compound. Drug Dev Res 22:239-250.
52. Schotte A, Janssen PFM, Gommeren W (1996) Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology 124:57-73.
53. 4 receptors elevated in schizophrenia. Nature 365:441-445.
54. Skarsfeldt T (1992) Electrophysiological profile of the new atypical neuroleptic, sertindole, on midbrain dopamine neurones in rats: acute and repeated treatment. Synapse 10:25-33.
55. Skarsfeldt T (1993) Comparison of the effect of substituted benzamides on midbrain dopamine neurones after treatment of rats for 21 days. Eur J Pharmacol 240:269.
56. Skarsfeldt T (1994) Comparison of short-term administration of sertindole, clozapine and haloperidol on the inactivation of midbrain dopamine neurons in the rat. Eur J Pharmacol 254:291-294.
57. Skarsfeldt T (1995) Differential effects of repeated administration of novel antipsychotic drugs on the activity of midbrain dopamine neurons in the rat. Eur J Pharmacol 281:289-294.
58. Skarsfeldt T (1996) Differential effect of antipsychotics on place navigation of rats in the Morris water maze. Psychopharmacology 124:126-133.
59. Spencer DG, Lal H (1983) Effects of anticholinergic drugs on learning and memory. Drug Dev Res 3:489-502.
60. Stockton ME, Rasmussen K (1996a) Electrophysiological effects of olanzapine, a novel atypical antipsychotic, on A9 and A10 dopamine neurons. Neuropsychopharmacology 14:97-104.
61. Stockton ME, Rasmussen K (1996b) Olanzapine, a novel atypical antipsychotic, reverses d-amphetamine-induced inhibition of midbrain dopamine cells. Psychopharmacology 124:50-56.
62. 2 antagonist ritanserin blocks the effect of pre-frontal cortex inactivation on rat A10 dopamine neurons in vivo. Acta Physiol Scand 136:497-498.
63. 1-adrenoceptor antagonism. J Clin Psychopharmacol 16 (suppl 1):11S-18S.
64. Tamminga CA, Mack RJ, Granneman GR, Silber CJ, Kashkin KB (1997) The comparative efficacy and safety of sertindole. Int Clin Psychopharmacol 12 (suppl 1):S27-S33.
65. Valjakka A, Riekkinen P, Sirviö J, et al. (1990) The effect of dorsal noradrenergic bundle lesions on spatial learning, locomotor activity and reaction to novelty. Behav Neural Biol 54:323-329.
66. White FJ, Wang RY (1983a) Comparison of the effects of chronic haloperidol treatment on A9 and A10 dopamine neurons in the rat. Life Sci 32:983-993.
67. White FJ, Wang RY (1983b) Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons. Science 221:1054-1057.